BCLI · Brainstorm Cell Therapeutics Inc. · Investor Relations
$0.84
-0.33 (-28.21%)
At close · Jul 18
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Such conditions raise substantial doubts about the Company’s ability to continue as a going concern. Management’s plan includes raising funds from outside potential investors, however, as mentioned above, there is no assurance such funding will be available to the Company or that it will be obtained on terms favorable to the Company or will provide the Company with sufficient funds to meet its objectives.”View the 10-Q filed Aug 14, 2026
Market Cap
$10.81M
Shares
11.03M
Volume · Jul 18
819.7K
Avg daily vol (3M)
1.39M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2025-05-19 | Brainstorm Cell Therapeutics - Corporate Update | Event |
Source: http://ir.brainstorm-cell.com/